RP-70676

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRP-70676
Drug Alias NameRP-70676
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcyl coenzyme A:cholesterol acyltransferase inhibitors
TargetsAcyl coenzyme A:cholesterol acyltransferase
Therapy Area/IndicationsLipid Metabolism Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsLipid Metabolism Disorders

Other Information

ATC CodeN/A
Related LinksN/A